---
title: Lung pathology analysis with Immunoassays
image: https://medlab.tosoh-diagnostics.com/hubfs/Remote_diagnostics_environments.jpeg
---

# Lung function analysis

### ![dreamstime_xl_70621432 Lung](https://medlab.tosoh-diagnostics.com/hs-fs/hubfs/stockimage/dreamstime_xl_70621432%20Lung.jpg?width=450&name=dreamstime_xl_70621432%20Lung.jpg)Krebs von den lungen-6 (KL-6)

 

Interstitial lung diseases (ILDs) are a heterogeneous group of conditions, with a wide and complex variety of imaging features. Difficulty in monitoring, treating and exploring novel therapies for these conditions is in part due to the lack of robust, readily available biomarkers1. A majority of patients with ILD is characterised by considerable delays, frequent misdiagnosis, exposure to costly and invasive diagnostic procedures, and substantial use of healthcare resources2.  
Increased KL-6 serum concentrations were observed in patients with severe pulmonary involvement, revealing a prognostic value and supporting the potential usefulness of KL-6 measurement to evaluate COVID-19 patients' prognosis.

 

[![Contact Us](https://no-cache.hubspot.com/cta/default/19644636/3ce2a9f9-35ca-4745-8ea2-7c3fd9d40aff.png)](https://cta-redirect.hubspot.com/cta/redirect/19644636/3ce2a9f9-35ca-4745-8ea2-7c3fd9d40aff)

 

References:

1 Murray CJL, Piot P. The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection? JAMA. Published online March 03, 2021. doi:10.1001/jama.2021.2828

2 Grabmeier J, 2021, More than 87,000 scientific papers on coronavirus since pandemic (2021, February 23) [https://medicalxpress.com/news/2021-02-scientific-papers-coronavirus-pandemic.html](https://medicalxpress.com/news/2021-02-scientific-papers-coronavirus-pandemic.html)

 

![](https://px.ads.linkedin.com/collect/?pid=3667065&fmt=gif)